Dirk Reyn
InvestorManaging Partner at Bioqube Ventures
Antwerp, Belgium
Writes $100K β $5M checks Β· typically $1.5M
About
Dirk Reyn is Advisor and Managing Partner of Bioqube Factory Fund I with over 35 years of leadership in pharma and biotech. He began at Eli Lilly and Janssen-Cilag (J&J), co-founded and led Movetis NV to IPO and acquisition by Shire, founded Progress Pharma, and chaired Flanders.bio.
Invests in
Biotech
Experience
- NPM CapitalHealth Advisorcurrent2024 β presentAmsterdam Area
- Bioqube VenturesManaging Partnercurrent2016 β presentBrussel/Mechelen
- Egle TherapeuticsBoard Membercurrent2021 β present
- Progress PharmaChairmancurrent2013 β presentBelgium
- Enhanced GenomicsBoard Member2024 β 2025Cambridge, England, United Kingdom
- FlandersBioMedviaBoard Member2025Ghent, Flemish Region, Belgium
- flanders.bioPresident - Voorzitter van de Raad van Bestuur2018 β 2025
- Across HealthChairman of Board2018 β 2020Gent Area, Belgium
- SpectricityCo-founder and Board member2018 β 2020Leuven
- Rotary InternationalPast President Rotary Turnhout2017 β 2018Turnhout
- eTheRNA ImmunotherapiesFounding CEO2016 β 2017Niel, Belgium
- ZembroBoardmember2015 β 2016Gent
- TiGenixBoardmember2011 β 2016Leuven
- BbyBShareholder and executive coach2011 β 2016Brugge - Antwerpen - London - Tokyo
- Horizon Pharmaventures BVBADirector2011 β 2014Vosselaar, Belgium
- Shire PharmaceuticalsVP New Business Opportunities ISP region2012 β 2013Turnhout
- Shire PharmaceuticalsResolor Product General Manager2010 β 2012Turnhout
- Shire-MovetisManaging Director at Shire-Movetis NV2010 β 2013Turnhout
- Movetis NV.CEO and founder2006 β 2010Turnhout
- J&JVP New Business Development EMEA2003 β 2006
Education
- Hogeschool AntwerpenMBA, Master of Business Adminstration1986 β 1988
- University of Antwerpmaster in pharmacy1979 β 1984
Skills & more
Board AdministrationBoard LevelBoard GovernanceBiotechnology75Lifesciences36Healthcare21Change Management20Coaching5Start-ups49Business Planning30R&D16Business Strategy72
+10 more
Project ManagementClinical DevelopmentMarketing StrategyNew Business DevelopmentClinical ResearchProduct ManagementClinical TrialsSales ManagementStrategic PlanningPharmaceutical IndustryLanguages Dutch Β· English Β· French Β· German
From Dirk's professional profile.
Same school
Also attended University of Antwerp39
Jan AvontsInvestment Director at Capricorn Venture PartnersWim Van LooverenFinance Director at Heran PartnersChris ThoenChairman of the Scientific Advisory Board & IC Member (PeakBridge Growth II) at PeakBridge VCJohan van MilAdvisor at PeakFilip KegelsOperational Partner at Astanor VenturesRik DuyckBestuurder at Angelwise
+ 33 more
Shared employers
Also worked at flanders.bio1
Also worked at Spectricity1
Also worked at Rotary International13
Courtney SawatzkeEarly-stage Investor at Active PartnersLucile BeaumeSenior Associate at BreegaSerhat PalaGeneral Partner at Breakaway Partners OΓBrenda HalloranBoard of Directors; District Governor at Rotary International at Waterloo Accelerator CentreViktorija TrimbelInvestor at LitBANGrΓ©goire MaistreInvestor at Amadeus Capital SA
+ 7 more
Also worked at eTheRNA Immunotherapies2
Colleagues at Bioqube Ventures
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Geert Tackaert
Finance Director at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Janine Schuurman
Senior Advisor at Bioqube Ventures
Jon Edwards
Managing Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures
Network5
Alexander Demoulin
Associate at Bioqube Ventures
Clement Salque
Associate at Bioqube Ventures
Debora Dumont
Managing Partner at Bioqube Ventures
Jacques Mizrahi
Venture Partner at Bioqube Ventures
Joris De Maeyer
Executive in Residence at Bioqube Ventures
Investors connected to Dirk in public investor directories β a warm-intro map.






















